Reports
Reports
Analgesics refer to a term that refers to a class of drugs that are used to relieve pain without causing a loss of consciousness. Opioid analgesics have been widely adopted throughout the world and are widely recognized as the most efficient and broadly used drugs for treating severe pain. The goal of improving healthcare outcomes promotes global demand for analgesics such as pain management, which necessitates a multidisciplinary approach. Aside from that, manufacturers' composition of opioid analgesics with abuse-deterrent properties has created a high demand for analgesics worldwide. The growing prevalence of chronic and neuropathic pain are considered key factors augmenting the sales growth of the global non-opioid analgesics market during the forecast period set between 2021 and 2031.
The Non-opioid Analgesics market is classified on the basis of drug class, indication, route of administration, distribution channel, and region. Based on drug class, the market is grouped into opioids, NAIDs, acetaminophen, and local anesthetics. Among these, the opioids segment is again grouped into buprenorphine, dextromethorphan, oxycodone, tramadol, methadone, meperidine, fentanyl, codeine, morphine, and others. With respect to indication, the market is categorized into neuropathic pain, cancer pain, surgical pain, and others. On the basis of route of administration, the market is categorized into transdermal, parenteral, oral, and others. In terms of categorization by distribution channel, the market is grouped into online pharmacies, drug stores, retail pharmacies, and hospital pharmacies.
The research report on Non-opioid Analgesics market provides an elaborate overview of the market and its prime growth parameters. This includes drivers, restraints, challenges, and future growth opportunities. The report also throws light on the key innovations that made positive contribution to the market in terms of revenue generation. The impact of the novel COVID19 pandemic is also discussed in the report. List of the notable players and their efforts in the form of innovations and new product launches is also discussed in details. For more information on this report, log on to the company website.
The nature of competition for the global market is highly fragmented due to the presence of a multiple players. Leading players of the Non-opioid Analgesics market are using multiple strategies such as introducing innovative products to attract more revenues to the market. Other players are engaging in merger and acquisition, and joint ventures and collaborative efforts to create revenue generation opportunities for the Non-opioid Analgesics market in the coming years.
Some of the key players of the global Non-opioid Analgesics market include:
The increasing prevalence of opioid addiction and painkiller abuse has resulted in the development of various types of abuse-deterrent technologies. Over the forecast period, the advancement of production facilities across regions with limited novel drug delivery systems will create lucrative growth opportunities for the non-opioid analgesics market. The advent of non-opioid analgesics in emerging markets where opioid and non-opioid drugs with novel drug delivery systems are not easily available for pain management opens up opportunities for the analgesics market to grow.
Regionwise, this market is widespread into the regions of Latin America, Europe, North America, and the Middle East and Africa. These regions are further categorized as per the nations bringing business. North America emerged as the largest revenue generator for the Non-opioid Analgesics market owing to the presence of major players, coupled with the high recommendation of pain management drugs. Besides this, Europe and Asia Pacific markets will also generate notable revenues in the forecast period on account of the rising rate of chronic pain cases, and medical upgradation in terms of therapeutics and diagnostics.
N/A
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Non-opioid Analgesics Market
